Compare
Quest Patent Research Corp vs Natural Health Trends Corp vs Educational Development Corp vs Hydrofarm Holdings Group, Inc.
| Latest fiscal year | Quest Patent Research Corp QPRC | Natural Health Trends Corp NHTC | Educational Development Corp EDUC | Hydrofarm Holdings Group, Inc. HYFM |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-02-28 | 2025-12-31 |
| Revenue | n/a | $39.78M | $22.91M | $134.25M |
| Revenue growth (YoY) | n/a | -7.4% | -33.0% | -29.4% |
| Gross margin | n/a | 73.5% | 59.4% | 11.3% |
| Operating margin | n/a | -4.5% | n/a | -206.3% |
| Net margin | n/a | -2.2% | 10.1% | -215.9% |
| Net income | -$8.49M | -$882.0K | $2.33M | -$289.79M |
| EPS (Diluted) | -$1.59 | -$0.08 | $0.27 | -$62.35 |
| Operating cash flow | -$5.92M | -$6.00M | $2.01M | -$14.06M |
| Free cash flow | n/a | -$6.07M | $1.46M | -$15.08M |
| Cash & equivalents | $192.6K | $6.81M | $1.12M | $6.31M |
| Total assets | $10.44M | $38.43M | $54.31M | $123.80M |
| Total liabilities | $27.63M | $15.00M | $11.52M | $187.10M |
| Shareholders' equity | -$17.19M | $23.43M | $42.79M | -$63.30M |
| Return on year-end equity | n/a | -3.8% | 5.4% | n/a |
| Shares outstanding | 5.33M | n/a | 8.51M | 4.67M |
Revenue, most recent five fiscal years
| Fiscal year | Quest Patent Research Corp | Natural Health Trends Corp | Educational Development Corp | Hydrofarm Holdings Group, Inc. |
|---|---|---|---|---|
| Latest | $2.79M Ended 2024-12-31 | $39.78M Ended 2025-12-31 | $22.91M Ended 2026-02-28 | $134.25M Ended 2025-12-31 |
| 1 year earlier | $13.15M Ended 2023-12-31 | $42.96M Ended 2024-12-31 | $34.19M Ended 2025-02-28 | $190.29M Ended 2024-12-31 |
| 2 years earlier | $451.2K Ended 2022-12-31 | $43.92M Ended 2023-12-31 | $51.03M Ended 2024-02-29 | $226.58M Ended 2023-12-31 |
| 3 years earlier | $2.05M Ended 2021-12-31 | $49.13M Ended 2022-12-31 | $87.83M Ended 2023-02-28 | $344.50M Ended 2022-12-31 |
| 4 years earlier | $5.49M Ended 2020-12-31 | $60.01M Ended 2021-12-31 | $142.23M Ended 2022-02-28 | $479.42M Ended 2021-12-31 |